Details for New Drug Application (NDA): 021338
✉ Email this page to a colleague
The generic ingredient in IONSYS is fentanyl hydrochloride. There are thirty-one drug master file entries for this compound. Additional details are available on the fentanyl hydrochloride profile page.
Summary for 021338
Tradename: | IONSYS |
Applicant: | The Medicines Co |
Ingredient: | fentanyl hydrochloride |
Patents: | 8 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYSTEM;IONTOPHORESIS, TRANSDERMAL | Strength | EQ 40MCG BASE/ACTIVATION | ||||
Approval Date: | May 22, 2006 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 1, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 30, 2031 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | May 21, 2032 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | METHOD FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF FENTANYL HYDROCHLORIDE |
Expired US Patents for NDA 021338
Complete Access Available with Subscription